Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy

Acta Neurologica Scandinavica

Volumn 108, Issue 6, 2003, Pages 424-427

  Portela, L V C ^a,b   Tort, A B L ^a   Walz, R ^c   Bianchin, M ^c   Trevisol Bittencourt, P C ^d   Wille, P R ^e   Cardoso, R C ^e   Ishida, M M I ^d   VonWangenheim, A ^d   Grisard, E C ^e   Steindel, M ^e   Goncalves C A ^a   Souza, D O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b SEMSA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^e Fort Malakoff Park   (Germany)

Author keywords

EEG; Epilepsy; Neurocysticercosis; S100B; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; PROTEIN S100B;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GENE FREQUENCY; GLIA CELL; HUMAN; MALE; NEUROCYSTICERCOSIS; SEX RATIO;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; NERVE GROWTH FACTORS; NEUROCYSTICERCOSIS; S100 PROTEINS;

EID: 10744219589     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00159.x     Document Type: Article

References (25)

1. DUCHENE M, BENOUDIBA F, IENECKER C, HADJ-RABIA M, CALDAS J, DOYON D. Neurocysticercosis. J Radiol 1999;80:1623-27.
2. PAL DK, CARPIO A, SANDER JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000;68:137-43.
3. DEL BRUTTO OH. Neurocysticercosis. Rev Neurol 1999; 29:456-66.
4. RIGATI M, TREVISOL-BITTENCOURT PC. Cause of late-onset epilepsy in an epilepsy clinic of Santa Catarina - Southern Brazil. Arq Neuropsiquiatr 1999;57:787-92.
5. CARPIO A, ESCOBAR A, HAUSER WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998;39:1025-40.
6. KHURGEL M, IVY GO. Astrocytes in kindling: relevance to epileptogenesis. Eplepsy Res 1996;26:163-75.
7. JANKOWSKY JL, PATTERSON PH. The role of cytokines and growth factors in seizures and sequelae. Prog Neurobiol 2001;63:125-49.
8. PRADHAN S, KATHURIA MK, GUPTA RK. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol 2000;48:181-87.
9. DONATO R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999;1450:191-231.
10. GONÇALVES DS, LENZ G, KARL J, GONÇALVES CA, RODNIGHT R. Extracellular S100B protein modulates ERK in astrocyte cultures. Neuroreport 2000;11:807-9.
11. WONG CH, ROONEY SJ, BONSER RS. S100beta release in hypothermic circulatory arrest and coronary artery surgery. Ann Thorac Surg 1999;67:1911-14.
12. INGEBRIGTSEN T, WATERLOO K, JACOBSEN EA, LANGBAKK B, ROMNER B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioural outcome. Neurosurgery 1999;45:468-75.
13. WUNDERLICH MT, EBERT AD, KRATZ T, GOERTLER M, JOST S, HERRMANN M. Early neurobehavioural outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999;30:1190-5.
14. GAZZOLO D, VINESI P, BARTOCCI M et al. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 1999;170:32-5.
15. SHENG JG, MRAK RE, ROVNAGHI C, KOZLOWSKA E, VAN ELDIK LJ, GRIFFIN WS. Human brain S100B and S100B mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging 1996;17:359-63.
16. LARA DR, GAMA CS, BELMONTE-DE-ABREU P, PORTELA LVC et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 2001;35:11-14.
17. WALZ R, PORTELA LVC, TORT ABL et al. Serum S100B levels in patients with HTLV-I associated myelopathy/tropical spastic paraparesis. Neurology 2000;54:2021-22.
18. PORTELA LV, TORT AB, SCHAF DV et al. The serum S100B concentration is age dependent. Clin Chem 2002;48:950-52.
19. TREVISOL-BITTENCOURT PC, SILVA NC, FIGUEIREDO R. Prevalence of neurocysticercosis among epileptic patients in the west of Santa Catarina - southern Brazil. Arq Neuropsiquiatr 1998;56:53-8.
20. LEITE JP, TERRA-BUSTAMANTE VC, FERNANDES RMF et al. Calcified neurocysticercotic lesions and post-surgery seizure control in temporal lobe epilepsy. Neurology 2000;55:1485-91.
21. RAJSHEKHAR V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465-70.
22. MISSLER U, WIESMANN M, EHLERMANN P et al. Validation and comparison of two solid-phase immunoassays for the quantification of S-100B in human blood. Clin Chem 2000;46:993-6.
23. GRIN WS, YERALAN O, SHENG JG et al. Overexpression of neurotrophic cytoquine S100B in human temporal lobe epilepsy. J Neurochem 1995;65:228-33.
24. STEINHO BF, TUMANI H, OTTO M et al. Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res 1999;36:75-82.
25. PALMIO J, PELTOLA J, VUORINEN P, LAINE S, SUHONEN J, KERÄNEN T. NORMAL CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. J Neurol Sci 2001;183:27-31.